Press Release September 3, 2019

Elanco to Buy Bayer’s Animal-Health Unit for $7.6 Billion

Alston & Bird acted as counsel to Credit Suisse, the financial advisor to Bayer AG, in the proposed sale by Bayer of its animal-health business to Elanco Animal Health Inc. in a cash and stock deal valued at $7.6 billion.

Alston & Bird consistently ranks among the top 10 law firms representing financial advisors in M&A as reported annually by Corporate Control Alert, the legal and financial dealmaking journal. In 2018, the firm acted as counsel to financial advisors in 19 deals with a total value of approximately $57 billion, earning it the No. 7 ranking among counsel to investment banks involving U.S. companies in deals valued at $100 million or more.

Advising Credit Suisse is Alston & Bird partner Stuart Rogers of the firm’s Financial Advisors Practice.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement